MedPath

Intensive Motor Rehabilitation With Technology for Patients With Central Neurological Disease

Phase 2
Recruiting
Conditions
Chronic Disease
Stroke
Spinal Cord Injuries
Interventions
Other: Intensive rehabilitation programme
Registration Number
NCT05970367
Lead Sponsor
KU Leuven
Brief Summary

This project will consist of 1 large clinical trial with 2 core concepts: (1) Clinical benefits of an intensive rehabilitation programme using advanced technology, compared to the control group; (2) A full health economic evaluation combined with model-based estimation of costs and benefits.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria

  1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures;

  2. A diagnosis of central neurological disease, made by a specialist. Conditions may include stroke or spinal cord injury:

    1. Stroke: Participants must have received a diagnosis of stroke for the first time, have been diagnosed at least 3 months ago, and live at home.
    2. SCI: Participants have a rating A, B, C or D on the American Spinal Injury Association (ASIA) measurement scale, which refers to patients with complete or incomplete impairment. All levels of SCI can be included, if there is a clear patient need linked to the upper and/or lower extremities.

  3. At least 3 months post discharge from hospital/rehabilitation centre, living at home;

  4. Having a maximum recovery of 85% of independence in daily functioning (FIM/SCIM);

  5. Had a normal functional state prior to the pathology: a pre-pathology Barthel Index > 85/100;

  6. Unilateral or bilateral weakness of the affected upper or lower limbs (No maximum score in all affected limbs = motricity index: score 5 on 3/3 segments)

  7. Having the clinical opportunity to engage in exercise therapy with available technology, assessed by a specialist;

  8. Age of > 18 years;

  9. Sufficient cognitive ability to understand the games and give informed consent, assessed by a specialist;.

Read More
Exclusion Criteria
  1. Having other neurological or musculoskeletal conditions that may affect the protocol, assessed by a specialist;
  2. No ability to initiate movements against gravity in the upper and lower limbs;
  3. Severe visual impairment, communication, cognitive and language formation problems that would prevent the intervention and measurement process, assessed by a specialist;
  4. Any disorder, which in the investigator's opinion might the compromise participant's safety or compliance with the CIP;
  5. Female who is pregnant, breast-feeding.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intensive rehabilitation programIntensive rehabilitation programme3 weeks of intensive rehabilitation --\> follow-up 9 months standard care
Primary Outcome Measures
NameTimeMethod
Change in Functional Independence Measure (FIM)Baseline - 3weeks - 9months

The Functional Independence Measure (FIM), which measures independence in daily functioning after stroke. The FIM consists of 18 items designed to assess to what extent a person needs assistance in performing activities of daily living safely and efficiently. The activities consist of a number of basic skills related to self-care, pelvic floor function, transfers, gait, communication and social abilities. The FIM has acceptable reliability and has been found valid in people with stroke.

Min: 13; Max: 91; Higher = better

Change in Spinal Cord Independence Measure (SCIM)Baseline - 3weeks - 9months

Spinal Cord Independence Measure (SCIM), an assessment of achievements of daily function of patients with spinal cord lesions. The scale consists of 19 tasks organized in 3 subscales: self-care, respiration and sphincter management, and mobility. The SCIM is valid and reliable.

Min: 0; Max: 100; Higher = better

Secondary Outcome Measures
NameTimeMethod
Change in The Canadian Occupational Performance Measure (COPM)Baseline - 3weeks - 9months

The Canadian Occupational Performance Measure (COPM), is an evidence-based outcome measure designed to capture a patient's self-perception of performance in everyday living, over time. This outcome can be used in both study populations.

Min: 1; Max: 10; Higher = better

Change in EQ-5D-5LBaseline - 3weeks - every month during follow-up - 9 months

EQ-5D-5L, measures quality of life at five levels of health (mobility, self-care, daily activities, pain/discomfort and anxiety/depression). From this, a weighted health index can be calculated for an individual or population. This scale can also be used for both populations.

Min: 1; Max: 100; Higher = better

Change in Goal Attainment Scaling (GAS)Baseline - 3weeks - 9months

Goal Attainment Scaling (GAS), is an individualised evaluation method. It is scored on an ordinal 5-point scale, which captures a person's individual treatment goal and is scored afterwards on the achievement of that treatment goal. The GAS can and will be used for both stroke and spinal cord injury.

Min: -2; Max: +2; Higher = better

Change in The fatigue severity scale (FSS)Baseline - 3weeks - 9months

The fatigue severity scale (FSS) contains 9 questions assessing the perceived severity of fatigue symptoms in the past week in various daily situations. The patient indicates the extent to which fatigue determines functioning. Again, this will be used for both stroke and spinal cord injury.

Min: 9; Max: 63; Higher = worse

Borg Rating of Perceived Exertion ScaleDuring intervention (up to 9 months)

During the intervention the Borg Rating of Perceived Exertion Scale will be completed to after every therapy block to assess subjective experiences of the patients during physical load.

Min: 6; Max: 20; Higher = worse

Change in the action research Arm Test (ARAT)Baseline - 3weeks - 9months (stroke only)

The action research Arm Test (ARAT) is an observational measure to assess upper extremity performance (coordination, dexterity and functioning), including 19 items. Task performance is rated on a 4-point scale, ranging from 0 (no movement) to 3 (movement performed normally).

Min: 0; Max: 57; Higher = better

Change in the 10 Meter Walk Test (10MWT)Baseline - 3weeks - 9months (stroke only)

The 10 Meter Walk Test (10MWT) measures the time needed for a person to walk 10 meters. It is used to determine functional mobility and gait.

Change in the 6-minute Walk-Test (6MWT)Baseline - 3weeks - 9months (stroke only)

The 6-minute Walk-Test (6MWT) is used to measure functional capacity. The maximum distance the patient can cover within 6 minutes is measured.

Change in rhe Fugl-Meyer Assessment (FMA)Baseline - 3weeks - 9months (stroke only)

The Fugl-Meyer Assessment (FMA) is designed to assess motor functioning in upper and lower limbs, in patients with post-stroke. Patients are assessed on 50 test items and on an ordinal 3-point scale.

Min: 0; Max: 100; Higher = better

Change in the functional Ambulation Classification (FAC)Baseline - 3weeks - 9months (stroke only)

The functional Ambulation Classification (FAC): is a functional walking test that evaluates ambulation ability. This 6-point scale assesses ambulation status by determining how much human support the patient needs when walking, whether or not they use a personal assistive device.

Min: 0; Max: 5; Higher = better

Change in the Stroke Self-efficacy QuestionnaireBaseline - 3weeks - 9months (stroke only)

The Stroke Self-efficacy Questionnaire Evaluate individuals' confidence in carrying out activities of daily living.

Min: 0; Max: 60; Higher = better

Trial Locations

Locations (2)

KU Leuven

🇧🇪

Leuven, Belgium

AZ Herentals

🇧🇪

Herentals, Belgium

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy